| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |